The late-stage trial will recruit about 25,000 people around the world to test the new vaccine from Moderna.View on euronews

The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

Dr Patrick Moore, the study's chief investigator and the National Institute for Health and Care Research (NIHR) director in the South West, stated that there are currently "no approved vaccines for norovirus anywhere in the world", and the only treatment available for severely ill patients in hospitals is intravenous fluids.

A vaccine to guard against the winter vomiting bug norovirus is set for a year-long groundbreaking NHS trial after early results showed it creates a “strong immune response”. It is hoped an effective norovirus vaccine,

The late-stage trial will recruit about 25,000 people around the world to test the new vaccine from Moderna. View on euronews

A groundbreaking vaccine for norovirus, the notorious winter vomiting bug, is set to enter final-stage trials in the UK within the next fortnight. Developed by Moderna using mRNA technology, the jab aims to combat three major strains of the highly contagious virus.

A vaccine for the vomiting bug norovirus is being trialled in the UK for the first time, with the hope it could cut the “burden on the NHS”, the Health Secretary has said. The new mRNA vaccine from Moderna will enter final stages of testing within the next two weeks,

A trial in the UK will see a norovirus given to patients with the Health Secretary hoping it will cut the “burden on the NHS”.

A first-of-its-kind vaccine against the vomit bug norovirus is being trialled in the UK, using the same tech employed in the Covid jab. Thousands of Brits end up in hospital every year due to the highly contagious virus,